Abstract:OBJECTIVETo investigate the expression of integrin beta3 and osteopontin (OPN) in eutopic and ectopic endometrium of adenomyosis.METHODSFrom January 2007 to July 2008, the endometrium specimens were collected from 43 patients with adenomyosis undergoing hysterectomy in Peking University First Hospital. Eutopic endometrium were 11 in proliferative phase and 32 in secretory phase (18 cases in mid-secretory phase) were collected. Ectopic endometriums were also collected. In the mean time, it was chosen 41 cases with pure subserous uterine myoma or cervical intraepithelial neoplasia (CIN) II-III treated by hysterectomy as controls including 12 endometrium in proliferative phase and 29 endometrium in secretory phase (19 cases in mid-secretory phase). The expression of Integrin beta3 subunit and OPN in the endometrium were assessed by immunohistochemical staining and quantitative real-time polymerase chain reaction.RESULTS(1) Immunohistochemical staining showed that positive staining of integrin beta3 and OPN were present predominantly in eutopic and ectopic endometrial glandular epithelium. There was significant different protein expression of integrin beta3 and OPN, which were 1.6 +/- 0.8 and 1.7 +/- 0.7 in eutopic endometrium, 1.7 +/- 0.7 and 1.8 +/- 0.9 in ectopic endometrium, 2.1 +/- 0.9 and 2.0 +/- 0.9 in control endometrium (P < 0.05). The protein expression of integrin beta3 and OPN in eutopic endometrium of adenomyosis in the proliferative phase (0.8 +/- 0.4 and 0.7 +/- 0.3) were remarkably lower than those of the secretory phase (1.8 +/- 0.8 and 1.9 +/- 0.8, P < 0.01). The protein expression of integrin beta3 and OPN in the endometrium of controls in the proliferative phase (1.0 +/- 0.4 and 1.0 +/- 0.4) were significantly lower than those of the secretory phase (2.5 +/- 0.7 and 2.5 +/- 0.7) (P = 0.000). In the mid-secretory phase, the protein expression of integrin beta3 (2.0 +/- 0.9) and OPN (2.1 +/- 0.8) in eutopic endometrium of adenomyosis were significantly lower than that of control endometrium (2.7 +/- 0.5 and 2.7 +/- 0.7) (P < 0.01). (2) The mRNA expression level of integrin beta and OPN in eutopic and ectopic endometrium were assessed by quantitative real-time PCR (result was shown by median index). It was observed that integrin beta3 mRNA and OPN mRNA were significantly lower in the eutopic endometrium of adenomyosis (4.69 and 4.23), when compared with ectopic endometrium (7.96 and 14.84) and controls (13.47 and 17.40) (P < 0.05). Eutopic endometrium had higher mRNA expression of integrin beta and OPN mRNA in the secretory phase (5.54 and 11.40) than that in the proliferative phase (2.69 and 3.30) (P < 0.01). The mRNA expression level of integrin beta and OPN of control endometrium in the proliferative phase (3.12 and 4.75) were significantly lower than that in the secretory phase (19.94 and 21.00, P = 0.000). The mRNA expression of integrin beta and OPN were 10.10 and 14.34 in the mid-secretory phase, which were significantly lower than 21.50 and 24.18 in control endometrium (P < 0.05).CONCLUSIONSHigh expression of integrin beta3 and OPN in ectopic endometrium of adenomyosis may cause endometriotic lesions; abnormal expression of integrin beta3 and OPN in the endometrium of adenomyosis during the implantation window may contribute to infertility in some patients.

Expression and Significance of Kiss-1 and Osteopontin in Ectopic and Eutopic Endometrium in Patients with Endometriosis

Research on the Expression of KISS-I/MMP-9 in Ectopic and Eutopic Endometrium from Women with Endometriosis and Its Biological Significances

Osteopontin Regulates Endometrial Stromal Cell Migration in Endometriosis Through the PI3K Pathway

Expression of Vascular Cell Adhesion Molecule 1 and Intercellular Adhesion Molecule 1 in Endometrium and Serum in Endometriosis

Elevated Expressions of SHP2 and GAB2 Correlated with VEGF in Eutopic and Ectopic Endometrium of Women with Ovarian Endometriosis.

[Expression of Suppressor of Cytokine Signaling-3 and Caspase-3 in Endometriosis and Their Correlation].

Expression and Significance of TLR3 in Eutopic and Ectopic Endometrium from Women with Endometriosis

Identification of Key Genes and Pathways in Endometriosis by Integrated Expression Profiles Analysis.

Overexpressed Mps-1 Contributes To Endometrioma Development Through The Nf-Kappa B Signaling Pathway

The expression of Twist and E -cadherin and its clinical significance in ovarian endometriosis

Decreased Expression of Pigment Epithelium-Derived Factor and Increased Microvascular Density in Ovarian Endometriotic Lesions in Women with Endometriosis.

Expression of aquaporins in eutopic and ectopic endometrium of patients with endometriosis

[Expression of Integrin Beta3 and Osteopontin in Endometrium of Patients with Adenomyosis].

The Expression of Kisspeptins and Matrix Metalloproteinases in Extragenital Endometriosis

Expression of Polo-Like Kinase 1 in the Ectopic and Eutopic Endometrial Tissue from Women with Endometriosis

Altered expression of interleukin-18 in the ectopic and eutopic endometrium of women with endometriosis

Expression of Integrin Β3 and Osteopontin in the Eutopic Endometrium of Adenomyosis During the Implantation Window.

Expression of Proliferation Cell Nuclear Antigen Ki-67 in Ectopic Endometrium and Eutopic Endometrium

Expression of Survivin and Bcl-2 in Endometriosis and Their Significance

Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients.

Expression of Vascular Endothelial Cell Growth Factor and Its Receptor Flk- 1 in Endometriosis